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Abstract 
A conditioned taste aversion (CTA) develops when exposure to a novel 
tastant is followed by sickness/malaise. Recently, it has been shown that a 
CTA can be reduced if the animal is placed in a social environment, i.e., in 
the presence of a conspecific, during the CTA acquisition phase. The 
current project was aimed to expand on our understanding of this 
phenomenon by (a) identifying the magnitude of an aversive response to a 
saccharin solution induced by lithium chloride (LiCl), a known emetic 
agent, in mice maintained in the social versus non-social setting; and (b) 
defining differences in LiCl-induced neuronal activation in the key CTA-
related forebrain areas of animals in the social and non-social scenario. In 
mice lacking social stimulation, LiCl at a dose of 1 mEq induced a mild 
CTA to saccharin and the 6-mEq dose produced a profound aversive 
response. On the other hand, 6 mEq was the lowest effective dose in mice 
kept in the social setting. Immunohistochemical analysis of a neuronal 
activity marker, c-Fos, showed that alteration of activity in the 
paraventricular nucleus of the hypothalamus (PVN) and central nucleus of 
the amygdala (CEA) is associated with the observed changes. In LiCl-
injected mice subjected to social stimulation, also the percentage of Fos-
positive oxytocin (OT), but not vasopressin neurons in the PVN was higher 
than in LiCl-treated single-housed mice. These results are discussed in 
context of the effects that sociality has on the magnitude of responses to 
adverse associative stimuli and an involvement of specific elements of 
brain circuitry in mediating these effects.  
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Introduction 
Food intake, while providing energy, nutrients and (to some extent) 
rewarding value – is a behavioural activity poised to expose an animal to 
the danger of toxicity. In the natural environment, the risk of edible 
plant/animal material harbouring toxins (oftentimes, not originating from 
the actual food source, but rather derived from external/secondary 
sources, such as bacterial/parasitic metabolites) is high [1]. Thus, the 
ability of the organism to avoid harmful substances is one of the key 
aspects of survival and is evolutionarily very well-conserved. Not 
surprisingly, behavioural avoidance of potentially toxic tastants has been 
shown in invertebrate and vertebrate species. Even unicellular protozoans 
reject bitter flavours that are typically associated with plant poisons [2].  
There are several behavioural and physiological mechanisms that allow an 
organism to minimise the likelihood of encountering food-derived toxins. 
One of them is food neophobia, a phenomenon where novel food is 
tentatively consumed in minute amounts, and these amounts increase with 
subsequent exposure to this ingestant, but only if the initial intake of this 
food did not result in gastrointestinal (GI) sickness [3]. Moreover, innate 
flavour preferences tend to reflect food toxicity risks associated with them 
and so bitter tastes, being characteristic for tainted foods, are generally 
avoided [4, 5]. Furthermore, many animal species are capable of expelling 
from the gut foods that cause an unpleasant gastrointestinal sensation, for 
example via the emetic reflex. An alternative to emesis is pica, a process 
in which the animal exposed to food toxicity and GI discomfort, ingests 
large amounts of non-nutritive substances, such as clay or soil [6], in an 
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attempt to decrease the concentration of a presumed toxin in the GI tract 
and to provide additional stimulation to gut mechanoreceptors, possibly 
being conducive to emesis [7]. Finally, there is a complex learning-based 
mechanism through which a risk of consuming toxic foods can be reduced, 
termed a conditioned taste aversion (CTA). This association-based 
learning process, described in detail below, allows the animal to avoid 
tastants whose intake has previously been followed by sickness/malaise. 
  Conditioned Taste Aversion 
In the natural environment, a CTA ensues when ingestion of a novel 
tastant leads to an unpleasant GI sensation within a relatively short 
timeframe. This facilitates a Pavlovian learning process that underlies 
avoidance of this particular food upon future presentation [8]. If the feeling 
of sickness occurs during a meal, it also promotes an immediate 
termination of ingestive behaviour. Subsequent presentations of an 
aversive food lead to complex responses underlying persistent 
hypophagia, including suppression of hunger, increase in anxiety and fear 
as well as memory-based avoidance. The CTA phenomenon is particularly 
crucial for those species (including rodents) that do not have an emetic 
reflex [9], and thus have to rely on a CTA as a key mechanism in a smaller 
repertoire of processes that minimise dangers of food-borne toxicity. 
In the laboratory setting, a CTA is typically induced by pairing presentation 
of a novel food (the unconditioned stimulus) with an injection of a noxious 
substance; usually lithium chloride (LiCl) or copper sulphate (CuSO4) are 
used to cause short-lived malaise (conditioned stimulus). The animal then 
associates the sickness with the novel food and will avoid it (conditioned 
3 
 
response) upon subsequent exposures [8]. A CTA test can be performed 
with any tastant of a characteristic flavour, however, the vast majority of 
the studies available in the literature use novel liquid tastants, especially 
the palatable and non-caloric 0.1% saccharin solution. Acquisition of a 
CTA is assessed by giving the animal a two-bottle choice test [10], in 
which saccharin versus water intakes are measured. Non-CTA animals 
drink more of the palatable saccharin, whereas aversive individuals 
consume mainly water in this choice scenario [11]. While CTAs form 
readily towards novel foods, they can also develop to foods that have 
been encountered before, however, it usually requires a much more robust 
sickness response and/or repetitions of associations between malaise and 
a previously consumed tastant  [12]. 
A CTA was first described by Garcia, who found that fluid and food intakes 
in rats were suppressed after exposure to sickness inducing low levels of 
gamma radiation [13]. Subsequent pairing of the radiation with food and 
water would further depress consumption [13]. Further studies showed 
that the only the GI discomfort-related type of conditioned stimulus could 
lead to the acquisition of a CTA – for example, electric shocks paired with 
a meal did not cause a CTA, however, associations with toxin injections or 
x-ray exposure produced a CTA [14]. Interestingly, aversion can also be 
induced by forced exercise that leads to GI motility changes [15]. A 2006 
study by Masaki and Nahajima compared the relative magnitudes of CTA 
developed by rats that were either forced to run, swim, run voluntarily, run 
optionally, or were treated with LiCl. While the injection generated the 
strongest aversion, forced exercise also invoked a CTA, with forced 
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running giving the greatest magnitude of an aversive response [16]. It was 
initially hypothesised that activity-based CTA was induced through 
physiological stress [17] or the energy expenditure [18]. However, a study 
in male rats that examined whether fighting between conspecifics would 
promote a CTA found that no aversion developed [19]. An alternative 
hypothesis to activity-based CTA is that there is gustatory discomfort: 
exercise inhibits emptying of the stomach, therefore, it is not the stress of 
exercise that causes the CTA, but rather the GI discomfort [20]. 
As mentioned in the introductory paragraphs to this thesis, a CTA is a 
complex phenomenon whose development relies on a vast array of 
intertwined processes, including stress, memory and reduced appetite.  
Intuitively, as any sickness is taxing (thus, stressful) for an organism, GI 
discomfort and malaise induce the activity of the hypothalamic-pituitary-
adrenal (HPA) axis [21, 22]. In fact, even transient GI tract discomfort may 
lead to long-lasting altered behaviours and digestive outcomes that persist 
despite complete resolution of the initial symptoms [23, 24]. Therefore, the 
CTA includes a stress component. For example, it has been shown that 
malaise-inducing doses of LiCl produce c-Fos immunoreactivity in the 
brain regions implicated in CTA, as well as activating the HPA axis and 
elevating plasma corticosterone levels in rats [25]. Administration of 
synthetic glucocorticoids at the time of LiCl CTA acquisition attenuates the 
development of aversion [26]. On the other hand, adrenalectomy does not 
affect CTA acquisition, but it does delay extinction unless corticosterone 
levels are restored via exogenous administration [25]. Aside from the HPA 
axis, the amygdala complex modulates CTA-driven hypophagia by 
5 
 
providing additional stress- and fear-related processing that aids in the 
proper manifestation of a CTA. The basolateral nucleus of the amygdala 
(BLA) is the receiver of sensory data that allows for the acquisition and 
expression of the fear response, whilst the central nucleus of the 
amygdala (CEA) is thought to be the generator of fear responses [27]. The 
CEA and BLA receive inputs from the hippocampus, hypothalamus, 
brainstem, and gustatory areas, and the CEA sends information back to 
the hypothalamus and brainstem, using information from other nuclei of 
the amygdala [28].  Activation of the BLA during aversion has been shown 
through Fos activation [29], and some lesion studies suggested that BLA 
is necessary for CTA acquisition [30-34]. While some studies show the link 
between a CTA and these two nuclei of the amygdala, the results are 
somewhat conflicting [35]. For example, Zimmerman et al found that when 
the BLA was lesioned, the CEA could still facilitate conditional fear 
responses after overtraining [36]. 
Glucocorticoids are not just critical in stress-related processing, but also 
affect another component of a CTA, memory [37] (the multi-faceted role of 
glucocorticoids serves as an example of a functional overlap of the 
neuroendocrine systems that contribute to the complexity of aversive 
responses). The key anatomical site for CTA memory – especially the 
memory for the initial excitatory conditioning - is the insular cortex through 
which brain-derived neurotrophic factor increases an aversive memory-
trace [38, 39]. On the other hand, N-methyl D-aspartate (NMDA) receptors 
in the dorsal medial prefrontal cortex are needed for CTA memory 
consolidation, highlighting the complexity of medial pre-frontal cortex 
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functions [40]. Surprisingly, the role of the hippocampus in CTA memory is 
relatively limited. Hippocampal lesions do not block a CTA, but promote 
increased sensitivity to latent inhibition [41, 42]. There is no evidence 
linking the hippocampus with CTA memory retrieval [43], but this memory-
related brain region does facilitate the renewal of CTA following extinction 
[44]. 
Finally, a successful avoidance of tainted food requires an abrupt 
termination of food intake: this hypophagic response should occur despite 
the energy needs of the organism as well as despite the palatability (and 
consequently motivating) value of the potentially tainted food. Thus, 
intricate neural and neuroendocrine mechanisms that ensure an 
immediate cessation of ingestive behaviour are the particular interest of 
research focused on unravelling the role of critical factors modifying 
aversive responses that go well beyond the classically envisioned basic 
learning paradigm. The following sections delineate the foundations of 
mechanisms that affect food intake and describe how these mechanisms 
tie with aversive responses.   
1.1.1.  Appetite regulation: basic concepts 
Food intake is driven to a large extent by energy needs as well by the 
rewarding (palatability) aspects of consumption. Therefore, neural circuits 
responsible for the regulation of food intake encompass pathways that 
control the hedonic (pleasure) and the homeostatic (caloric) facets of 
eating behaviour [45]. These pathways are summarised in Figures Figure 
1 and Figure 2, where Figure 1 depicts the hedonic circuit, and Figure 2 
gives an overall view of the chief brain pathways regulating food intake.  
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Figure 1: Schematic representation of neural circuits that regulate feeding. Dopaminergic 
neurons originating in the VTA project to neurons within the nucleus accumbens of the 
ventral striatum. The lateral hypothalamus receives input from GABAergic projections from 
the nucleus accumbens as well as melanocortinergic neurons from the Arc of the 
hypothalamus. In addition, melanocortin receptors are also found on neurons in the VTA 
and the nucleus accumbens. Figure modified from Homeostatic and hedonic signals interact 
in the regulation of food intake [45] 
 
Figure 2: A schematic representation of the chief brain pathways involved in the regulation 
of eating behaviour. ARC, arcuate nucleus; NTS, nucleus of the solitary tract; CCK, 
cholecystokinin; GLP-1, glucagon-like peptide 1; PYY, peptide YY. PVN, paraventricular 
nucleus; LHA, lateral hypothalamic area; PFA, perifornical area; NPY, neuropeptide Y; 
AGRP, Agouti-related peptide; POMC, pro-opiomelanocortin; CART, cocaine- and 
amphetamine-related transcript; CRH, corticotrophin-releasing hormone; TRH, thyrotropin-
releasing hormone; OX, oxytocin; MCH, melanin-concentrating hormone. From 
Neuronendocrine control of food intake [46] 
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The key components of the homeostatic network include the host of 
brainstem and hypothalamic sites, with the hindbrain acting as a relay 
station for peripheral signals [47] and the hypothalamus providing 
neuroendocrine feedback into the periphery as well as the input into other 
Central Nervous System (CNS) areas. There are many specific pathways 
within the brainstem-hypothalamic circuit involved in this process. One of 
them is activated by signalling from the gastrointestinal (GI) tract (Figure 
2), which stimulates (via vagal afferents) neurons in the nucleus of the 
solitary tract (NTS), which then provide information onto primary-order 
neurons in the arcuate nucleus (ARC). The ARC also contains cells that 
express leptin receptors and glucose sensing molecules, thereby being 
capable of receiving direct information from the periphery regarding 
energy stores and energy availability [48]. Thus, second order neurons 
from the paraventricular nucleus of the hypothalamus (PVN) or the lateral 
or periformical hypothalamic area (LHA/PFA) can be activated via the 
ARC-derived input in response to signals from adipose sources. The PVN 
and LHA/PFA neurons can  also be activated directly by projections from 
the NTS and from other brainstem sites, such as the area postrema and 
dorsal motor nucleus of the vagus [46]. This hypothalamic-brainstem 
pathway provides dispersed input into a vast network of other brain sites 
that are not directly involved in the regulation of energy balance, and these 
areas (via reciprocal innervation with the brainstem-hypothalamic pathway 
and with each other) modulate feeding responses by incorporating other 
processes that shape ingestive behaviour including stress, reward, and 
sociality [46]. 
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Rewarding aspects of consumption are mediated via the hedonic pathway 
whose key component is the mesolimbic system [49]. Activity of the 
reward system is increased upon exposure to stimulation associated with 
pleasure (aside from food intake, it also occurs in conjunction with any 
rewarding behavioural activity, including reproductive behaviours, social 
behaviours, etc). This activity is further increased upon repeated 
experiences with rewarding stimuli so that eventually the activity of the 
reward system itself motivates the animal to seek them [50]. In line with 
that, the reward system is responsible for increasing behaviours that 
enhance an animal’s search for and intake of palatable foods [51]. The 
brainstem-hypothalamic pathway is – to some degree – a gateway into the 
reward system. Food intake stimulates the ARC: the ARC activates the 
mesolimbic pathway via projections sent directly to the VTA that initiate 
the cascade of neural events which leads to the release of VTA-derived 
dopamine in the nucleus accumbens [45]. This is the basis for 
reinforcement of eating behaviour by food via dopamine release. The VTA 
also receives oxytocin (OT) innervation from the PVN [52], which is 
thought to promote termination of intake of palatable tastants [53]. 
1.1.2.  Appetite-related neural and neuroendocrine systems in 
CTA development 
As mentioned earlier, an immediate termination and/or subsequent hunger 
reduction in the presence of an aversive tastant are the fundamental 
aspects of a CTA. Therefore, many of the key sites known to be involved 
in this process include those that regulate appetite. When a 
sickness/malaise is induced, the brain networks responsible for 
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termination of food intake are stimulated. C-Fos data show that, following 
the injection of LiCl, brainstem and hypothalamic areas exhibit enhanced 
activity [54, 55]. This reflects the fact that GI discomfort is mediated 
vagally whereas chemoreception of blood-borne toxins occurs via 
microcirculation around the hindbrain areas where the blood brain barrier 
(BBB) is weak. Consequently, the peripheral signalling related to a CTA 
affects the dorsal vagal complex (DMNV and NTS – for vagally mediated 
changes; and AP for plasma toxicity) [56]. The area postrema (AP) plays a 
critical role in inducing emesis [57]. This effect was discovered in 1953 by 
Borison and Wang, who discovered that AP ablation causes a decrease in 
vomiting rates and this stems from the fact that the AP contains 
chemoreceptors [58]. Berger et al. investigated whether thermal lesions of 
the AP alleviate a CTA (what they termed ‘bait shyness’). They saw that 
lesioned rats were less likely to develop “bait shyness” to those that were 
sham lesioned, confirming that the AP is critical for the development of 
CTA [59]. This attenuation of CTA through AP ablation has been further 
corroborated by multiple studies [60-65]. A recent report showed that 
lesions of the AP lead to a significantly lower level of brain activity (defined 
through immunohistochemical detection of an immediate-early gene 
product,  c-Fos)  in the amygdala, PVN, supraoptic nucleus of the 
hypothalamus (SON), and parabrachial nuceus (PBN), regions that 
therefore may depend on the AP input to properly integrate the full 
strength of a CTA signal. The magnitude of activation of these regions was 
correlated with the magnitude of a CTA [55]. 
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Aversive treatments have been shown to induce c-Fos also the NTS [54, 
66]. Bilateral lesions in the NTS impair taste aversion learning, however 
these lesions do not affect a CTA if the aversion is exclusively due to 
blood-borne substances, which evoke the response via the AP without 
affecting the vagal component of the CTA pathways [67]. 
Fibres from the NTS project to the PBN [54]. A 2014 study showed that 
interactions between the PBN and the amygdala were essential for 
developing a normal CTA, whereas lateral hypothalamic-PBN pathways 
were crucial for the speed of acquisition and rate of extinction of a CTA as 
shown in asymmetric LHA-PBN lesion studies [68]. The hypothalamus 
hosts two other sites that shape aversive responsiveness, the PVN and 
SON. Both of these sites encompass OT neurons and they show 
heightened c-Fos immunoreactivity after treatments that cause a CTA [69-
71].  
While the brainstem-hypothalamic circuit plays a key role in an immediate 
cessation of consummatory behaviour, it also reciprocally communicates 
with – among others - the amygdala and prefrontal cortex, thereby 
ensuring the consolidation of various facets of CTA-related activity (i.e., 
stress-, memory- and appetite-related) within the dispersed neuronal 
network [72-74]. 
Interestingly, many anorexigenic peptides at the peripheral and CNS level 
serve as mediators of hypophagia in CTA. In the periphery, 
cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide YY 
(PYY) seem to be crucial in evoking aversion-driven termination of 
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ingestive behaviour. CCK, released from the gut, decreases food intake 
via afferent vagal pathways, primarily by inhibiting gastric acid secretions 
and gastric emptying [75, 76]. Intravenous (IV) CCK infusions induce the 
release of OT, a hypothalamic peptide that reduces consumption for 
energy, consumption for reward as well as promoting discontinuation of 
feeding when internal milieu is jeopardised (see section 2.2 for more 
detail). Interestingly, taste stimuli previously paired with IV CCK induce 
neurohypophyseal release of OT even in anaesthetised rats, which 
underscores the likely involvement of the CCK-OT functional 
(multisynaptic) pathway in associative learning of food avoidance [77]. It 
should be noted that CCK itself is capable of inducing a CTA [78], and this 
effect can be prolonged through coupling CCK to a 10 kDa polyethylene 
glycol, which increases the time CCK is present in the general circulation 
and thus enhances exposure time of CCK1 receptor to its ligand [79]. 
Overall, the CCK findings exemplify the fact  that endocrine processing of 
aversive responses originates already at the gut level, and the GI tract 
acts as the gateway to processing behavioural responses to potentially 
dangerous foods. This notion is supported by data pertaining to other gut 
molecules. PYY is released from the GI tract into circulation following a 
meal, and it reduces food intake and gastric motility when administered 
peripherally [80-82]. Similar to CCK, peripheral PYY can induce a dose-
dependent CTA, and thus its appetite reducing effects (under some 
circumstances) may be due to its aversive properties [83]. Similarly, gut-
derived GLP-1, a GI motility inhibitor released at the end of a meal [84], 
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induces a CTA [85], though its aversive properties seem to be mediated 
by a very select subset of brain sites [86].  
At the CNS level, a number of anorexigenic peptides have been shown to 
be linked to aversive responsiveness as well. Oxytocin (described in detail 
in section 1.2.1) is the final component of the circuitry that ensures the 
development of a CTA.  Melanocortin (MC) receptor agonists (especially 
those that bind to MC3 receptors) have been found to cause a CTA [87]. 
Furthermore, corticotropin releasing hormone (CRH), one of the most 
potent anorexigens defined to date, has also been found to cause aversive 
consequences [88]. 
Overall, the fact that such a vast array of anorexigenic peptides (both 
peripheral and central) support aversion and induce cessation of 
consummatory behaviour that endangers internal milieu strongly indicates 
that there is a functional overlap in aversion and hypophagia promoting 
mechanisms. This reflects the necessity for the aversive and anorexigenic 
processes to be at least somewhat coordinated via common pathways. 
Interestingly, while anorexigenic peptides aid in shaping the full spectrum 
of CTA responsiveness, orexigenic molecules oftentimes appear to 
prevent the development of aversion. It has been shown that an 
endogenous MC3/MC4 receptor antagonist, Agouti-related protein (AgRP) 
alleviates aversive consequences of pairing LiCl administration with an 
intake of a novel ingestant [89]. The reward system seems to be 
particularly effective in suppressing anorexigenic responses to toxic foods. 
This is most likely facilitated by inhibitory input of opioid peptides that 
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mediate reward by silencing the activity of satiety pathways, including 
those of the brainstem and the hypothalamus. For example, Olszewski et 
al (2000) found that various subclasses of opioid peptides suppress 
acquisition of LiCl-induced CTA in rats acquainted with opioid ligand 
treatment [90]. In line with those findings, Flanagan et al [91] reported that 
opioid receptor blockade with naloxone potentiates anorexigenic and 
aversive consequences of LiCl and CCK treatments.  
1.1.2.1.  Oxytocin and Vasopressin as Key 
Neuroendocrine Systems involved in CTA formation 
Oxytocin (OT) and vasopressin (VP) are structurally similar 
neurohypophysial hormones, whose molecules differ only by two amino 
acids (Figure 3).  
 
Figure 3: Amino acid sequences of oxytocin (OT) and vasopressin (VP). Figure modified 
from The Oxytocin-Oxytocin Receptor System and Its Antagonists as Tocolytic Agents [92] 
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These highly conserved peptides are present in all vertebrates except 
cyclostomes [93, 94]. Gene duplication that occurred early in the evolution 
gave rise to the mammalian OT-VP system [95]. Similar to the peptide 
molecules, their respective receptors are thought to have arisen through 
gene duplication and subsequent divergence to produce the unique 
receptors. These receptors belong to the G protein-coupled family, four of 
which are found in humans and rodents: three for VP (V1a-R, V1b-R, and 
V2-R), and one for OT (OTR). OTR and V1a-R are most abundantly 
expressed within the brain [96], though V1b-R receptors are also found in 
the anterior pituitary [97]. While OTR has equal affinity for both OT and 
VP, the V1a-R receptor has greater selectivity, with a 30-fold greater 
affinity for VP over OT [98]. 
OT and VP are synthesised mainly in the hypothalamus: in the PVN and 
SON, in the accessory nuclei between these two regions, as well as – in 
the case of VP – in the suprachiasmatic nucleus (SCN) [99, 100]. The 
magnocellular neurons of the PVN and SON deliver OT and VP to the 
neurohypophysis and throughout the CNS, whereas parvocellular neurons 
of the PVN provide only innervation within the CNS [96, 101, 102].  
Classically, OT is described as a peptide that promotes parturition and 
milk ejection, whereas VP is known to have anti-diuretic properties through 
its action on water reabsorption in the kidney [103-105]. Importantly, OT 
and VP support termination of ingestive behaviour and participate in the 
formation of a CTA.  
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As anorexigens, OT and VP appear to terminate feeding in order to protect 
homeostasis. For example, OT release occurs upon excessive stomach 
distension caused by voracious consummatory activity [106]. The OT 
system is also stimulated by an increase in plasma osmolality – a typical 
occurrence associated with consumption of salty tastants. Lesions of the 
PVN, where OT neurons are amassed, cause a loss-of-control overeating 
[107, 108], and this excessive consumption continues despite a gradual 
decline in parameters signifying internal milieu. OT also reduces feeding 
for reward – especially intake of carbohydrates and sweet non-
carbohydrate tastants is affected [109-112]. The role of VP in the 
regulation of consumption has been mainly linked with the control of 
osmotic balance, and this homeostatic role fits in the general function of 
VP in kidney processes and blood pressure regulation [113-115]. In line 
with those findings, intra-peritoneal VP injections induce inhibition of food 
intake, but they also affect thirst [116]. 
Both OT and VP support CTA development. Neurohypophysial secretion 
of OT and VP has been observed following administration of aversion 
inducing toxins [117]. Aversive treatments stimulate activation of OT and 
VP neurons in the PVN and SON (defined by c-Fos expression analysis), 
and pharmacological strategies that reduce CTA decrease activation of 
OT and VP cells [90]. Furthermore, blocking OT receptors blunts the 
magnitude of  LiCl-induced aversion, and a reduction in activation levels of 
the CEA is a likely culprit [71].  
17 
 
1.1.2.2.  A cross-link between the regulation of food intake 
and social behaviour: do oxytocin and vasopressin 
play a role? 
The vast majority of data on how OT and VP affect CTA development and 
food intake have been collected in studies on single-housed animals. 
However, it should be noted that consumption in social species usually 
has a social component. In fact, how much animals eat, when they eat, 
whether they consider food as safe, and when they stop eating, is to at 
least some extent driven by social interactions. Because of that 
phenomenon, there has been a recent surge in studies defining the link 
between appetite and the social context of consumption. Simultaneously, 
neuroendocrine systems that affect both food intake and sociality have 
attracted a lot of attention. Interestingly, OT and VP belong to this 
category. 
Oxytocin promotes social behaviour by supporting the development of 
mother-child interactions, pair bonding as well as in-group social 
behaviours [118-120]. OT induces behaviours that have been described 
initially as “altruistic”, although the current consensus is that these are in 
fact behaviours that benefit a given group of individuals [121-123]. 
Interestingly, disruption of the OT signalling by administration of the OT 
receptor blocker leads to abnormal feeding behaviour in mice given 
access to a meal in a social setting [124].  
Similarly to OT, VP plays roles in maternal stress, social behaviour, and 
sexual motivation [125]. VP receptor blockade in the olfactory bulb impairs 
social recognition in rodents [126]. VP-null Brattleboro rats given VP via 
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microdialysis show improved social recognition [127]. Increasing the VP 
tone in rats improves social memory [128]. Mice lacking V1a-R receptors 
have poor social recognition [129].  
When VP is injected centrally via the lateral ventricle, extinction rate of 
LiCl-induced CTA rapidly increased [130]. This was also confirmed via 
peripheral administration of VP [131], but these were in low doses that did 
not induce a CTA on their own. High doses of VP given after LiCl 
injections delay extinction of the CTA, and also strengthen its acquisition, 
and can also induce a CTA when injected alone. Hayes and Chambers 
believe that this was due to avoidance-inducing properties of VP [132].   
Despite this link with sociality, it is not known whether a social context of a 
CTA might affect OT or VP signalling, thereby modifying aversive 
responsiveness of socially housed animals that learn to associate an 
unpleasant GI sensation with a novel food. This is a striking gap in our 
knowledge especially considering the fact that a 2015 short 
communication by Hishimura revealed that the ability to interact with 
conspecifics during a CTA acquisition phase reduces the magnitude of an 
aversive response [133]. Thus, a certain social buffering system – possibly 
associated with OT and/or VP – might be underlying a blunted sensitivity 
to unpleasant GI sensation that would otherwise lead to a reduction in the 
intake of a tainted ingestant.  
 
  
19 
 
  Overarching Goal and Specific Aims 
The development of a CTA is a complex process that relies on a 
combination of appetite, memory, and stress processes. Recently, a short 
communication has been published in which it was shown that interaction 
with a conspecific reduces the magnitude of a CTA response. In the 
current set of studies, I wished to provide a detailed characterisation of the 
phenomenon of social environment as a factor modifying responsiveness 
to aversive stimuli. I have therefore sought to: 
1. Determine the minimum dose of an aversive agent (LiCl) that is required 
to induce a CTA in a social vs non-social setting; 
2. Determine LiCl-induced patterns of brain activity (defined by marking c-
Fos immunoreactivity) in CTA-related forebrain sites in a social vs non-
social setting; 
3. Determine activation of OT and VP neurons induced by the same dose 
of an aversive agent (LiCl) in a social vs non-social setting.  
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Materials and Methods 
  Experiment 1: Effect of LiCl on the acquisition of a CTA in 
mice housed in a non-social environment 
Animals:  
40 male C57 mice aged 12 weeks old were single-housed in standard 
mouse cages with wire tops in a temperature-controlled (22°C) animal 
facility with a 12:12 hour light:dark cycle (lights on at 0700). Food 
(Sharpes Feed) and water were available ad libitum unless stated 
otherwise.  
Experimental Procedure: 
Animals were divided into five treatment groups (n=8): control (saline), 0.6, 
1, 3, and 6 mEq of LiCl. Each group was exposed for one hour to a  0.1% 
saccharin solution after overnight water deprivation solution, and then 
immediately injected intraperitoneally (i.p.) with vehicle (saline) or LiCl. 
Three days later, both saccharin and water were presented to the animals 
in a 2-bottle choice test after overnight water deprivation and the amount 
of saccharin consumed by each animal was recorded.  
  Experiment 2: Effect of LiCl on the acquisition of a CTA in 
social mice 
Animals:  
40 male C57 mice aged 12 weeks old were pair housed in standard 
mouse cages with wire tops in a temperature-controlled (22°C) animal 
facility with a 12:12 hour light:dark cycle (lights on at 0700). Cages were 
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divided by a wire mesh such that mice had partial social contact in order to 
avoid agonistic interactions. Food (Sharpes Feed) and water were 
available ad libitum unless stated otherwise.  
Experimental Procedure: 
Animals were divided into five treatment groups (n=8): control (saline), 0.6, 
1, 3, and 6 mEq of LiCl. Each group was exposed to a 0.1% saccharin 
solution after overnight water deprivation solution, and then immediately 
injected i.p. with vehicle (saline) or LiCl. Three days later, both saccharin 
and water were presented to the animals in a 2-bottle choice test after 
overnight water deprivation and the amount of saccharin consumed by 
each animal was recorded.  
  Experiment 3: Effect of Social Housing versus Non-Social 
Housing on neuronal activity in mice following injection of 
Lithium Chloride 
Animals: 
24 male C57 mice aged 12 weeks old were pair housed in standard plastic 
cages with wire tops in a temperature-controlled (22°C) animal facility with 
a 12:12 hour light:dark cycle (lights on at 0700). Food (Sharpes Feed) and 
water were available ad libitum unless stated otherwise.  
Experimental Procedure: 
Mice were pair housed for a minimum of seven days and 12 mice were 
divided into two groups (n=6): 1) pair-housed LiCl and 2) pair-housed 
Saline (Sal). Group 1 received a 1 mL 6 mEq LiCl solution injection, and 
Group 2 received a 1mL saline injection. Food was removed immediately 
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after the injection and euthanasia of groups 1 and 2 was performed 60 
minutes after injections (see euthanasia below). 
The remaining 12 mice were single-housed for seven days, and were 
divided into two groups (n=6): 3) Single-housed LiCl and 4) Single-housed 
Sal. Group 3 received a 1mL 6 mEq LiCl solution injection, and Group 4 
received a 1 mL saline injection. Food was removed immediately after the 
injection and euthanasia of groups 3 and 4 was performed 60 minutes 
after injections (see euthanasia below). 
Euthanasia and Perfusion: 
Sixty minutes post injection, mice were deeply anaesthetised with 1 mL 
35% urethane, and perfused intracardially with 50 mL of 4% 
paraformaldehyde (PFA) in a 0.1 mol L-1 phosphate buffer (pH 7.4), and 
their brains were dissected out.  
Immunohistochemistry: 
Coronal sections of 60 µM were cut on a Vibratome (Leica), and 
processed as free-floating sections. All intermediate tissue rinsing was 
done four times with Tris-buffered saline (TBS) on a rocking table, and all 
incubation procedures were done in a Supermix solution of 0.25% gelatin 
(Sigma) and 0.5% Triton X-100 (Sigma) in TBS.  
Single staining for c-Fos: Tissue was first treated for 10 minutes in 3% 
H2O2 in 10% methanol (MeOH) (in TBS), then rinsed and incubated 
overnight at 4°C in polyclonal goat anti-c-Fos antibody (1: 1000, Santa 
Cruz). After rinsing, sections were incubated for 1 hour at room 
temperature in a secondary biotinylated rabbit-anti-goat antibody (Vector 
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Laboratories) (1:400 in Supermix), then rinsed and subsequently 
incubated for 1 hr in the avidin-biotin complex (Vector Laboratories). After 
additional rinsing, sections were placed in a solution of 0.05% 
diaminobenzidine (DAB) (Sigma), 0.01% H2O2 and 0.2% nickel sulphate 
in TBS, in order to develop staining. 
Mounting:  
Sections were mounted on gelatinised microscope slides, dried, and 
dehydrated in ascending concentrations of ethanol, then soaked in xylene, 
and embedded in Entellan. 
Analysis: 
Sections were examined under a light microscope, acquiring images with 
a camera (Olympus DP70), and analysed using Scion image software. 
Four areas of interest were outlined using the neuroanatomical atlas by 
Paxinos and Watson - these areas were the paraventricular nucleus of the 
hypothalamus (PVN), nucleus accumbens (NAcc), basolateral nucleus of 
the amygdala (BLA), and central nucleus of the amygdala (CEA). Each 
region was counted using ImageJ software cell counter plugin and the 
area was recorded using scale. Percentages of active neurons per square 
mm were calculated. The data was averaged per animal, and then per 
experimental group.  
  Experiment 4: Effect of Social Housing versus Non-Social 
Housing on OT and VP neuronal activation in mice following 
injection of Lithium Chloride 
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The perfused and sectioned brain tissue from experiment three was used 
to perform double-immunohistochemistry with c-Fos and OT as well as c-
Fos and VP.  
 Double staining for c-Fos and Oxytocin: The method outlined above 
for single-staining of c-Fos was performed. The procedure for the oxytocin 
double-staining involved repeating the same procedure after the 
completion of c-Fos staining, with overnight incubation in rabbit anti-
oxytocin antibody (Vector Laboratories) followed by incubation in 
secondary biotinylated goat anti-rabbit (Vector Laboratories) antibody. The 
oxytocin staining was developed in a 0.05% diaminobenzidine (DAB), 
0.01% H2O2 in TBS solution without nickel sulphate. 
 Double staining for c-Fos and Vasopressin: The method outlined 
above for single-staining of c-Fos was performed. The procedure for the 
vasopressin double-staining involved repeating the same procedure after 
the completion of c-Fos staining, with overnight incubation in polyclonal 
sheep anti-vasopressin antibody (Millipore) followed by incubation in 
secondary biotinylated rabbit anti-sheep (Vector Laboratories) antibody. 
The vasopressin staining was developed in a 0.05% diaminobenzidine 
(DAB), 0.01% H2O2 in TBS solution without nickel sulphate. 
Mounting:  
Sections were mounted on gelatinised microscope slides, dried, and 
dehydrated in ascending concentrations of ethanol, then soaked in xylene, 
and embedded in Entellan. 
Analysis:  
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Slides were examined under a light microscope, and a cell count was 
performed by the experimenter. Areas of interest (PVN) were identified 
and outlined using the neuroanatomical atlas were identified, and the total 
numbers of oxytocin/vasopressin neurons were counted. Subsequently, 
using the c-Fos staining, total numbers of active oxytocin/vasopressin 
neurons were counted. A neuron was considered active if the c-Fos stain 
fell within the oxytocin/vasopressin stain, signalling an active nucleus of 
that neuron. The total numbers of active oxytocin/vasopressin neurons 
were calculated as a percentage of the total number of 
oxytocin/vasopressin neurons.  
Statistics:  
Results are presented as means ± SEM. All data was analysed using two-
way ANOVA. Post hoc comparisons were performed using a Fisher’s test 
for Experiment 1 and 2, and a Tukey test for experiment 3, with a 
significance level of p<0.05. Values were considered significantly different 
when p<0.05.  
All experiments had prior approval of the Animal Ethics Committee at the 
University of Waikato.  
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Results 
  Experiment 1: LiCl reduces consumption of 0.1% saccharin in 
mice housed in a non-social environment 
LiCl injections paired with exposure to a novel diet (saccharin) in non-
socially housed mice induced a CTA at concentrations of 1 mEq LiCl and 
above, which was confirmed three days later in a two-bottle choice test. 
The reduction of saccharin consumption as a result of the LiCl injection 
follows a dose-response curve (Figure 4).  
 
Figure 4: The effect of 0 (saline), 0.6, 1, 3 and 6 mEq of LiCl on acquisition of a CTA to a 0.1% 
saccharin solution in mice housed in a non-social setting. LiCl was administered IP just after 
the initial exposure to the saccharin solution. A CTA was established in a two-bottle test in which a 
choice between water and saccharin was given. The data are shown as % of saccharin solution 
intake in the cumulative fluid intake. *, **, *** = significantly from saline (p = <0.05, <0.01, and 
<0.001 respectively). 
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  Experiment 2: A higher dose of LiCl is necessary to induce a 
CTA in mice housed in a social environment 
LiCl injections paired with exposure to a novel diet (saccharin) in socially 
housed mice failed to induce a CTA at the same concentrations as in mice 
housed in a non-social environment. Only at the highest concentration of 
LiCl, 6 mEq, was a reduction in saccharin intake 3 days after the injection 
measured (Figure 5).   
 
Figure 5: The effect of 0 (saline), 0.6, 1, 3, and 6 mEq of LiCl on acquisition of a CTA to a 
0.1% saccharin solution in mice housed in a social setting. LiCl was administered IP just after 
the initial exposure to the saccharin solution. A CTA was established in a two-bottle test in which a 
choice between water and saccharin was given. The data are shown as % of saccharin solution 
intake in the cumulative fluid intake. *, **, *** = significantly from saline (p = <0.05, <0.01, and 
<0.001 respectively). 
  Experiment 3: Social versus non-social housing differentially 
affects c-Fos IR in LiCl-treated mice  
A significant increase in c-Fos immunoreactivity (IR) was observed in the 
PVN and CEA (p = 0.05 and <0.01 respectively), but none in the NAcc or 
BLA in non-socially housed mice injected with LiCl compared to socially 
housed mice injected with saline. The same increase in c-Fos IR in those 
areas was found in LiCl-treated mice housed in a social environment (p = 
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<0.01 for PVN, and 0.02 for CEA). For animals injected with LiCl, c-Fos IR 
was greater within the PVN and a significantly reduced in the CEA in mice 
that were socially housed compared to those that were isolated (p= 0.01 
and <0.01 respectively). This decrease of activation in the CEA was 
comparable to the isolated saline levels (Figure X). The socially housed 
saline treatment group had a decrease in activation of the NAcc compared 
to non-socially housed saline treatment group (p = <0.05). These results 
are summarised in Figure 6. 
 
Figure 6: Density of c-Fos nuclei in areas implicated in the development of a CTA. PVN – 
paraventricular nucleus of the hypothalamus; CEA – central nucleus of the amygdala; BLA – 
basolateral amygdala of the nucleus; NAcc – nucleus accumbens. δ = significantly different from 
Single Sal (p = <0.05). NS = Non-Socially housed, S = Socially Housed, Sal = saline, LiCl = lithium 
chloride. *, ** = significantly from saline (p = <0.05 and <0.01 respectively) 
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  Experiment 4: A social environment enhances LiCl-induced 
activity increase of OT neurons compared to a non-social 
environment 
Looking at the OT activation in PVN, there was no significant difference 
between the saline groups. Non-socially housed LiCl mice had greater 
activation of OT neurons in the PVN than non-socially housed saline 
(p<0.01), and socially housed LiCl had a greater activation of OT neurons 
compared to non-socially housed LiCl (p = <0.05). On the other hand, 
activation of VP neurons was only significantly different between non-
socially housed saline and non-socially housed LiCl/paired LiCl (p = <0.01 
and <0.05 respectively). Figure 7Figure 8 illustrate these results. 
Examples of photomicrographs used to collect data for experiments 3 and 
4 are illustrated in Figure 9Figure 10.  
 
Figure 7:  Effect of LiCl versus Saline on activity of OT neurons within the PVN in animals 
housed in a social verus non-social setting.  NS = Non-Socially housed, S = Socially Housed, 
Sal = saline, LiCl = lithium chloride. δ = significantly different from Single Sal (p = <0.05), * = 
significantly from Single LiCl (p = 0.05). 
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Figure 8: Effect of LiCl versus Saline on activity of VP neurons within the PVN in animals 
housed in a social verus non-social setting. No significant effects found within social 
comparison or non-social comparisons 
 
Figure 9: Photomicrographs depicting c-Fos immunoreactivity within the paraventricular 
nucleus of the hypothalamus (PVN) of mice injected with saline and non-socially housed (A), LiCl 
and non-socially housed (B), saline and socially housed (C), and LiCl and socially housed (D). 
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Figure 10: Photomicrographs depicting c-Fos immunoreactivity within the central nucleus of 
the amygdala (CEA) of mice injected with saline and non-socially housed (A), LiCl and non-
socially housed (B), saline and socially housed (C), and LiCl and socially housed (D). 
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Discussion 
An adverse event of either physiological or environmental nature (the 
latter, being subsequently “translated” to a certain set of physiological 
processes) typically triggers protective mechanisms whose goals include 
ensuring that the consequences of this event do not jeopardise 
homeostasis and that – if possible – the risks that this adverse event might 
reoccur are minimised. In appetite regulation, behavioural and 
neuroendocrine changes are in the forefront of processes preventing the 
animal from consuming foods that pose threat to internal milieu. What 
seems to be almost counterintuitive is that food-borne risk avoidance is 
extremely dynamic and can be modified by a variety of factors. The most 
commonly encountered aspect of this phenomenon is voracious 
overeating, which occurs (in humans and laboratory animals alike) upon 
presentation of highly palatable foods, especially in the intermittent fashion 
[134, 135]. Such foods are consumed in extremely large quantities upon 
multiple exposures, even though each of the previous overeating episodes 
would have resulted in excessive stomach distension and changes in 
plasma osmolality that activated a plethora of homeostatic mechanisms 
and produced sickness/malaise [45]. One can easily understand the need 
for such behavioural plasticity: finding the intricate balance between 
potential gains versus negative consequences of key behaviours, 
including food intake, is the key aspect of survival, especially in the 
evolutionary context of adaptation to the environment in which food is a 
scarce resource [135, 136]. Interestingly, we know very little about factors 
that are capable of shifting the risk-versus-gain scale by diminishing the 
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avoidance response. The current project has therefore offered a unique 
opportunity to examine social behavioural processes that influence 
acquisition of a conditioned taste aversion and define neural mechanisms 
that underlie the changed aversive response in LiCl-treated animals 
subjected to different social environment scenarios. 
At the first stage of the experimental trials, I established dose response 
curves for LiCl-induced CTA in socially housed versus non-socially housed 
mice. The results showed that animals that did not have social exposure 
were more sensitive to aversive properties of LiCl as they needed a much 
lower (6 times) dose of the drug to reduce consumption of saccharin in a 
two-bottle test, compared to the mice in the social environment.  
In 1955, Garcia made the initial observation that water and food intakes 
are suppressed following low doses of gamma radiation, but only if the 
ingestants are offered in containers that were used in the radiation 
chamber. Then, in order to study whether it was an associative learning 
phenomenon that took place, he developed a model of CTA in which rats 
were exposed to a 0.1% saccharin solution during a radiation treatment 
and he found that when the animals were later given simultaneous access 
to the saccharin solution and water (this time, in containers different from 
the ones used in the radiation chamber), they showed a significantly 
decreased preference for palatable saccharin [13]. When saccharin and 
water were presented to the rats daily for the next 60 days, the CTA 
animals gradually extinguished their aversive response, though the entire 
extinction process would require approximately 30 days. A CTA to 
saccharin was dose-dependent – the higher the dose, the greater 
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magnitude of an aversive response [13]. This paradigm in which a non-
caloric and palatable saccharin solution is used in a choice scenario 
against gustatorily neutral water was quickly adopted by other 
investigators interested in aversion and it has been successfully used 
since (included in the experiments presented here) to define aversive 
properties of treatments [10]. Pharmacological agents replaced radiation 
as standard means of inducing a CTA. Among them is LiCl that – upon 
intraperitoneal administration – consistently generates gastrointestinal 
discomfort, which is sufficient to produce a conditioned response in choice 
paradigms, including saccharin-water two-bottle tests. In fact, LiCl CTA 
has become a standard CTA model, most frequently used in biomedical 
and biopsychological studies involving laboratory animals [137]. Despite 
the consensus on the reliability of LiCl as a CTA inducing agent, some 
variability in responsiveness to LiCl has been noted. For example, a 
magnitude of an aversive response is not only species-, but also strain-
dependent: Long-Evans Hooded rats showed display a greater avoidance 
of a saccharin solution after an associative learning treatment (thus, a 
stronger CTA) than Sprague-Dawley rats [138]. The type of test used to 
determine the acquisition of a CTA to LiCl also affects a magnitude of the 
CTA – the use of a two-bottle choice test rather than just giving access 
just to a single tastant produces more pronounced outcomes [139]. For 
instance, the same dose of the aversive agent that produces a CTA in a 
two-bottle test is ineffective in reducing consumption of that tastant if the 
animal has no other choice of fluid [140]. Some sex differences occur 
when assessing CTA acquisition in rodents: Chambers and Sengstake 
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found that in females extinction of an LiCl-induced CTA to sucrose was 
faster than in males [141]. This discrepancy between sex and CTA 
development seems to be dependent partly on testosterone – 
gonadectomised males were less likely to develop a CTA compared to 
intact males, and administering testosterone to these males counteracted 
this effect [142]. Furthermore, younger animals are more resistant to CTA 
development, which is possibly due to the fact that taste information is 
more readily forgotten as it is not as salient in younger animals as in adults 
[143].  Another factor that changes the strength of a CTA is the number of 
conditioning trials – three trials versus one in mice induces a greater level 
of saccharin preference suppression, which is also reflected by further 
elevated c-Fos immunoreactivity in the NTS, PBN and CEA [144].  
Nachman and Ashe showed that the threshold dose for acquisition of a 
CTA to a saccharin solution using intraperitoneal injections of LiCl in rats 
was 0.15 mEq/kg, and that the strongest aversion to saccharin occurred at 
around 3 mEq/kg [145]. Most authors report that 1-3 mEq/kg range is 
effective in inducing aversion in rodent species. This is consistent with the 
results obtained herein for mice in the non-social environment: the 1 mEq 
dose of LiCl was sufficient to generate a CTA. The maximum response 
(i.e., the highest levels of statistical significance when compared to saline 
controls as well as the greatest percentage change) was achieved with 6 
mEq of LiCl. Similarly to other studies, once more pronounced aversive 
responses are achieved (such as with 6 mEq in the non-social scenario 
here), a preference for the palatable saccharin solution decreases by 50% 
or more. 
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 One of the most common features of the vast majority of CTA 
experiments available in the current literature is that they were performed 
in animals individually housed, and without any clear and predictable 
social contact. In such studies, single-housed animals are typically given 
access to a novel food, and following presentation of this stimulus, they 
are injected with LiCl. What seems to be a standard procedure may in fact 
constitute a confound per se, because it has been shown that social 
isolation has a profound impact on a vast array of responses to negative 
stimuli, as – for example - it affects depressive- and anxiety-like profile of 
an individual. Thus, a 2015 paper by Hishimura has produced a 
groundbreaking discovery demonstrating that a social environment affects 
the acquisition of a CTA. In that paper, a single LiCl dose (0.2 M LiCl at 20 
ml/kg b. wt.) was given right after exposure to a novel 0.2% saccharin 
solution in male mice, and the animals were either kept in isolation or they 
were placed in a social setting (with a male conspecific). Development of a 
CTA to saccharin was tested through a two-bottle test over the course of 3 
days. LiCl-treated mice paired with their conspecifics drank as much 
saccharin as non-CTA saline controls paired with conspecifics [133]. 
Importantly, animals maintained in isolation after the aversive treatment, 
developed a typical aversive response [133]. In the current set of 
experiments, we expanded on the Hishimura study and generated a full 
dose-response curve for LiCl-CTA in animals that were in the non-social 
environment. We then followed with the experiment in which the same 
dose range was tested in mice that had been housed socially. We found 
that, in non-social cohort, a 1-mEq dose was sufficient to develop a mild 
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CTA, and the 6-mEq dose decreased saccharin preference by 50%. On 
the other hand, in the social scenario, 6 mEq LiCl was the lowest effective 
dose. Not only was the dose higher, but also the magnitude of the 
aversive response was hampered: saccharin consumption dropped only 
by about 15%.  
Thus, the dose needed to induce a CTA when there is social contact is 
about 6 times higher than when the animal is isolated. It suggests that 
sociality is an important modifying factor in CTA acquisition and that social 
exposure appears to promote anti-aversive effects. It is still uncertain 
though what the exact mechanism underlying this interaction between 
aversion and sociality might be. Hishimura hypothesised that this effect 
could have been caused social stress producing analgesia [133]. He 
proposed that – since male mice show a number of agonistic behaviours 
upon social reintroduction [146] – anxiogenic aspects of the social 
environment might overshadow the process of associating the malaise 
with the novel saccharin solution. Therefore, according to this hypothesis, 
social stimulation would not have reduced aversion through mechanisms 
positive for the animal from the behavioural and physiological contexts, but 
rather would be processed as a more deleterious event than the GI 
discomfort associated with the novel flavour. Hishimura’s notion was 
based on the fact that in his study, there was full physical contact between 
the animals, allowing the mice to exhibit a complete spectrum of 
behaviours, including the agonistic ones [133]. In order to address this 
issue, the current set of experiments utilised a modified approach, in which 
social contact was only partially retained (through the wire mesh partition 
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of the cage), but the occurrence of agonistic behaviours and 
consequences of those was eliminated. Despite that, the anti-aversive 
effect of social stimulation persisted, which strongly indicates that 
agonistic facets of social interactions play (if at all) a much lesser role than 
initially proposed by Hishimura. 
The c-Fos data obtained here shed more light on neural and 
neuroendocrine processes underlying the hampered CTA responsiveness 
in the social setting.  
Our c-Fos data in the non-socially housed animals confirm earlier findings: 
activation of the PVN and CEA is elevated upon administration of LiCl at 
aversion promoting doses [32, 55, 69, 144]. Recently, an increase in the c-
Fos expression of another neuroanatomical subdivision of the amygdala, 
the BLA, along with the CEA, PVN, and SON, has been reported in 
response to LiCl treatment [71]. In this set of experiments, only a trend 
suggesting an increase was detected in the BLA, but even though it has 
only neared significance, it reflected overall changes in the hypothalamic 
and amygdala circuitry during CTA acquisition. Assuming this slight 
difference is not caused by an individual variability component of cohorts 
of animals used in those two distinct studies, another possibility could be 
that the BLA is more critical for the retrieval of CTA [147] – this is 
particularly likely since the earlier report looked at neuronal activity 
following CTA trials. However, in this experiment only one injection of LiCl 
was given and this was prior to perfusion, no actual CTA conditioning trials 
were performed, hence the BLA may not have been activated purely 
because of the lack of the associative learning context normally present in 
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the CTA. In fact, the injection of LiCl in absence of the associative 
scenario might have been more reflective of the anorexigenic aspect of an 
aversive response (rather than associative one), and therefore as a 
stimulus it was not sufficient to engage the BLA. 
This is in line with the unpublished findings from our laboratory showing 
that injections of an anorexigen, OT, in the BLA do not reduce energy- or 
palatability-driven food intake. On the other hand, the BLA participates in 
generating emotional value to events via associative learning [148].  
One of the candidate molecules I wished to investigate was OT, because 
of its pleiotropic role in food intake, social behaviour, and anxiety. While in 
the introduction it was stated that OT is an anorexigenic peptide, this is not 
entirely true. Instead, OT appears to modulate consumption of specific 
macronutrients, namely reduction of consumption of carbohydrates. Mice 
with OT gene deletions experience an enhanced intake of sucrose 
solutions both initially and sustained compared to mice without the gene 
deletion [112], and this increased preference is not seen for fats (intralipid) 
in these knockouts [149]. Administration of an OT-A increases sucrose 
intake in wild type mice, whether the sucrose solution contains intralipid or 
not. It had no effect on consumption of intralipid solutions alone, or on total 
calorie intake [149]. It is unclear whether it is specifically sweet tastes that 
OT inhibits consumption of, or if it is carbohydrate related. One study 
showed that OT knockout mice consumed greater amounts of saccharin, a 
non-nutritive sweetener, compared to wild type mice at all times of the 
dark:light cycle [150]. A more recent study showed that the use of an OT-A 
increased consumption of multiple sweet solutions (both nutritive and non-
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nutritive), and that gene expression of OT was increased after sucrose 
exposure, but not saccharin exposure. Sucrose was seen to be particularly 
sensitive to inhibition of OTR [151].  
In the present set of studies we observed a significant increase in activity 
of not only PVN neurons, but particularly of OT neurons within the PVN in 
both LiCl-treated groups: non-socially housed mice and mice exposed to 
social stimulation. This increase in OT neuronal activity is not surprising, 
as already Verbalis and colleagues in 1986 noted an increase in OT and - 
to a much lesser degree - VP release in response to LiCl in CTA animals 
[117]. However, our results indicate a much larger increase in OT neuronal 
activity in the socially housed LiCl-injected group compared to non-socially 
housed animals. OT neuronal activity is higher in animals housed in a 
social setting [152, 153], which means that the social component has a 
different influence on OT neurons and that in this case, we likely observed 
an additive effect of two distinct subpopulations of OT neurons: the first 
one mediating hyponeophagia, and the second one mediating sociality. 
Further studies are needed to decipher this effect, however, the increase 
in OT neuronal activity in socially stimulated animals may cause 
anxiolysis, resulting in a milder aversion following LiCl exposure. 
Administration of exogenous OT in rats causes anxiolysis [154]. It is 
possible that this effect is caused by the action of OT on the OTR in 
serotonergic neurons – Yoshida et al. demonstrated that the OTR was 
present in serotonergic neurons in mice, and when OT was infused 
centrally, serotonin was released from the median raphe nucleus, reducing 
anxiety-like behaviour. The anxiolytic effect of OT was blocked when a 
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serotonin receptor antagonist was infused, suggesting that OT can directly 
activate serotonergic neurons [155]. Another area of interest when looking 
at the anxiolytic effect of OT is the medial pre-frontal cortex (mPFC) – 
bilateral administration of OT into the prelimbic (PL) region of the mPFC in 
rats (both male and female) reduced anxiety-like behaviours, an effect that 
was not seen when VP or OT-A were administered [156]. The PL mPFC 
contains OTR-expressing neurons and receives long range OT projections 
from the hypothalamus – a 2015 thesis by Shirley Dong showed that 
exogenous OT in the PL mPFC reduced anxiety behaviours in rats, and 
this effect was blocked by GABA-receptor antagonists. The conclusion 
from this thesis was that attenuation of anxiety related behaviour by OT 
was performed through a GABAergic system [157]. In addition, another 
recent study demonstrated that intra-nasal administration of OT in humans 
enhanced connectivity between the mPFC and amygdala [158]. We did 
observe a decrease in c-Fos activity in the CEA in socially housed animals 
in the present set of studies. The CEA is the major output from the 
amygdala to the autonomic nervous system for expression of conditioned 
fear responses [159]. The CEA innervates both the hypothalamus and 
brainstem via efferent neurons [160]. It is necessary to establish fear 
learning – if inactivated, fear learning is disrupted, and protein synthesis 
inhibition within the CEA disrupts consolidation of memories relating to the 
fear learning [159]. Both the CEA and BLA are well established in the 
literature as being necessary for fear conditioning – electrolytic and 
ibotenic lesions of the CEA and NMDA-induced lesions of the BLA block 
fear-potentiated startles to conditioned stimuli [161, 162]. When rats were 
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made aversive to a strawberry flavoured solution, glutamate (a common 
excitatory neurotransmitter within the CNS) was released in the amygdala 
when re-presentation of the solution occurred, indicating activation of the 
amygdala in processing the response to this stimulus [163].   
The CEA is innervated by both OT and VP neurons [164] – however, in 
the social LiCl group, only OT neuron activation was significantly different 
in the PVN, not VP. This indicates that the underlying connection of social 
buffering is modulated by OT and not VP. 
László and colleagues recently published their findings demonstrating that 
direct administration of 10 ng OT bilaterally into the CEA attenuates 
anxiety in rats during elevated plus maze tests, and develops positive 
reinforcement during conditioned place preference testing [165]. In 
addition, a publication by Knobloch et al. revealed that when OT 
expressing axons were stimulated in vitro, a GABAergic circuit was 
activated that decreased output in the CEA. These findings were then 
confirmed in vivo through freezing responses in fear-conditioned rats 
[166]. GABA is an inhibitory neurotransmitter in the CNS, and is known for 
decreasing excitation neural circuitry.  
Within the CEA, the medial part is the region from which projections to the 
hypothalamus and brainstem stem [167]. The inhibitory effect of OT on the 
CEA acts through these medial neurons via activating GABA circuits. 
These GABA circuits are found in the capsular lateral parts of the CEA 
[164]. The behavioural and physiological effects of fear conditioning are 
regulated through the CEA by distinct neuron populations – OT affects the 
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behavioural response, without affecting the physiological response [72]. It 
has been shown that there are OT-positive axon terminals in the CEA, and 
that application of OT on the CEA can attenuate fear-related behaviours 
[168], indicating that our observations of decreased CEA activity in socially 
housed animals did not stem from hyponeophagia, but from mediating 
anxiolysis. 
In further studies, it would be beneficial to look at injecting an OT 
antagonist alongside LiCl and look at relative OT activation in the PVN and 
SON, and cFos activation in the CEA, to see if there is a drop despite 
there being social contact. This would help narrow down the correlation we 
see being caused by OT and not some unrelated mechanism. Alongside 
this, anxiety tests could also be measured in order to assess behaviourally 
whether anxiolysis is the main effect  
While in this thesis the focus of brain sites was the forebrain, it may be 
worth looking into hindbrain structures implicit in acquisition of a CTA, 
such as the AP and NTS.  While it is unlikely that social stimulation has a 
profound effect in these regions, it may be necessary to look at, especially 
considering the reciprocity of connections between the PVN and brainstem 
structures. Future studies would look into whether the brainstem displays 
different activity after social treatment.  
Other regions within the forebrain could also be investigated. The medial 
pre-optic area (MPOA) is a region associated with sociality and bonding 
[169, 170], and OT injections into this regions facilitate social recognition 
in rats [171]. The PL mPFC, which is involved in anxiety and expresses 
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OTR’s [157] may also play a role in the attenuation of CTA acquisition 
through innervation of the amygdala and may need to be investigated.  
Another direction to take this research could be to look at the role of 
sociality in extinction of a CTA. An experiment could be designed such 
that animals are separated after bonding, then made aversive to a novel 
food, and then look at whether returning social stimulation in the presence 
of this food will increase the rate of extinction, versus the social stimulation 
being absent. In this scenario, the BLA may also have varied activation, as 
it is involved in the retrieval of CTA memories, and this function might 
change when social stimulation is present. 
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Conclusions 
Overall, our data expand on our understanding in how sociality plays a 
role in attenuating the development of a CTA. Our results show that a 6–
times higher LiCl dose is required to induce a CTA in socially housed 
animals compared to single-housed mice. Immunohistochemical analysis 
of neuronal activity marker, c-Fos, showed that alteration of activity in the 
paraventricular nucleus of the hypothalamus (PVN) and central nucleus of 
the amygdala (CEA) is associated with the observed changes in 
responsiveness to the aversive treatment. Furthermore, in LiCl-injected 
mice subjected to social stimulation, also the percentage of Fos-positive 
OT, but not vasopressin neurons in the PVN is higher than in LiCl-treated 
single-housed mice. It underscores the importance of OT pathways in both 
sociality and aversive processes, however, it also suggests that distinct 
subpopulations of OT neurons might be contributing to each of these 
mechanisms in an independent manner. 
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